Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HOOKIPA Pharma Inc.HOOK · Entity 15295 | Chief Medical Officer | June 30, 2022 | July 01, 2022 |
| Immuneering CorpIMRX · Entity 5884 | Chief Medical Officer | February 03, 2026 | February 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HOOKIPA Pharma Inc.
Report date June 30, 2022 · Filed July 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.66 · Expires 2032-04-19 | Direct | 92,950 |
Reported balance
After 2022-06-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-30 · Grant · Acquired 92,950 · Balance 92,950 F1: 25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
Immuneering Corp
Report date February 03, 2026 · Filed February 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.91 · Expires 2036-02-03 | Direct | 140,000 |
Reported balance
After 2026-02-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-03 · Grant · Acquired 140,000 · Balance 140,000 F1: The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2026 Filed Feb 5, 2026 08:27 UTC | Immuneering Corp IMRX · Entity 5884 | GrantStock Option · Derivative | 140,000 | $0.00 Strike: $4.91 | $0.00 |
DisclosureSEC source: 0001790340-26-000028 · wk-form4_1770298047.xml · derivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Class A Common Stock · 140,000 shares Expires 2036-02-03 F1 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 16:12 UTC | Immuneering Corp IMRX · Entity 5884 | GrantStock Option · Derivative | 118,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001790340-25-000049 · wk-form4_1742847116.xml · derivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,000 Underlying: Class A Common Stock · 118,000 shares Expires 2035-03-21 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on March 17, 2026 and then in equal monthly installments over the subsequent three years, subject to the reporting person's continued employment through each applicable vesting date. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 16:11 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | GrantStock Option (Right to Buy) · Derivative | 92,950 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001104659-22-076824 · tm2220275-6_4seq1.xml · derivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,950 Underlying: Common Stock · 92,950 shares Expires 2032-04-19 F1 · derivative.exercise_date: 25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 16:27 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | GrantStock Option (Right to Buy) · Derivative | 92,950 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001104659-22-047853 · tm2213143-5_4seq1.xml · derivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,950 Underlying: Common Stock · 92,950 shares Expires 2032-04-19 F1 · derivative.exercise_date: 25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| February 01, 2022 Filed Feb 1, 2022 20:49 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | GrantStock Option (Right to Buy) · Derivative | 24,888 | $3.00 Strike: $1.50 | $74,664.00 |
DisclosureSEC source: 0001104659-22-010537 · tm225144-4_4seq1.xml · derivative · entry 2 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,888 Underlying: Common Stock · 24,888 shares Expires 2032-01-31 F2 · derivative.exercise_date: This stock option is fully vested. Read SEC document |
| February 01, 2022 Filed Feb 1, 2022 20:49 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | GrantCommon Stock | 14,933 | $3.00 | $44,799.00 |
DisclosureSEC source: 0001104659-22-010537 · tm225144-4_4seq1.xml · nonDerivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,240 F1 · shares: The Reporting Person was awarded 14,933 unrestricted shares of common stock as a portion of their base salary for the six month ending June 30, 2022. Read SEC document |
| December 21, 2021 Filed Jan 12, 2022 10:07 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,408 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001104659-22-003430 · tm222636-1_4seq1.xml · derivative · entry 9 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,261 Underlying: Common Stock · 3,408 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of this option vested and became exercisable on January 1, 2020, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 13,634 shares and the Reporting Person has exercised his option to purchase 9,373 shares. Read SEC document |
| December 21, 2021 Filed Jan 12, 2022 10:07 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,366 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001104659-22-003430 · tm222636-1_4seq1.xml · derivative · entry 8 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,842 Underlying: Common Stock · 11,366 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of this option vested and became exercisable on January 1, 2019, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 45,466 shares and the Reporting Person has exercised his option to purchase 42,624 shares. Read SEC document |
| December 21, 2021 Filed Jan 12, 2022 10:07 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,079 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001104659-22-003430 · tm222636-1_4seq1.xml · derivative · entry 7 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,079 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of this option vested and became exercisable on March 1, 2018, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 129,212 shares and the Reporting Person has exercised his option to purchase 129,212 shares. Read SEC document |
| December 21, 2021 Filed Jan 12, 2022 10:07 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | SaleCommon Stock | 2,205 | $2.49 | $5,490.45 |
DisclosureSEC source: 0001104659-22-003430 · tm222636-1_4seq1.xml · nonDerivative · entry 6 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,307 F1 · kind: The sales reported on this Form 4 were in connection with the satisfaction of tax obligations and the shares retained upon exercise remain subject to a lockup agreement which expires on March 8, 2021. Read SEC document |
| December 21, 2021 Filed Jan 12, 2022 10:07 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionCommon Stock | 3,408 | $0.10 | $340.80 |
DisclosureSEC source: 0001104659-22-003430 · tm222636-1_4seq1.xml · nonDerivative · entry 5 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2021 Filed Jan 12, 2022 10:07 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | SaleCommon Stock | 7,440 | $2.49 | $18,525.60 |
DisclosureSEC source: 0001104659-22-003430 · tm222636-1_4seq1.xml · nonDerivative · entry 4 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,104 F1 · kind: The sales reported on this Form 4 were in connection with the satisfaction of tax obligations and the shares retained upon exercise remain subject to a lockup agreement which expires on March 8, 2021. Read SEC document |
| December 21, 2021 Filed Jan 12, 2022 10:07 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionCommon Stock | 11,366 | $0.10 | $1,136.60 |
DisclosureSEC source: 0001104659-22-003430 · tm222636-1_4seq1.xml · nonDerivative · entry 3 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2021 Filed Jan 12, 2022 10:07 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | SaleCommon Stock | 5,304 | $2.49 | $13,206.96 |
DisclosureSEC source: 0001104659-22-003430 · tm222636-1_4seq1.xml · nonDerivative · entry 2 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,178 F1 · kind: The sales reported on this Form 4 were in connection with the satisfaction of tax obligations and the shares retained upon exercise remain subject to a lockup agreement which expires on March 8, 2021. Read SEC document |
| December 21, 2021 Filed Jan 12, 2022 10:07 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionCommon Stock | 8,079 | $0.10 | $807.90 |
DisclosureSEC source: 0001104659-22-003430 · tm222636-1_4seq1.xml · nonDerivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 16:36 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | GrantStock Option (Right to Buy) · Derivative | 95,250 | $0.00 Strike: $12.00 | $0.00 |
DisclosureSEC source: 0001104659-21-053191 · tm2113596-7_4seq1.xml · derivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,250 Underlying: Common Stock · 95,250 shares Expires 2031-04-19 F1 · derivative.exercise_date: 25% of this option shall vest on April 19, 2022, with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 16:04 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,965 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001104659-20-137408 · tm2038926d1_4.xml · derivative · entry 10 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,669 Underlying: Common Stock · 5,965 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of this option vested and became exercisable on January 1, 2020, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 13,634 shares and the Reporting Person has exercised his option to purchase 5,965 shares. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 16:04 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,367 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001104659-20-137408 · tm2038926d1_4.xml · derivative · entry 9 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,208 Underlying: Common Stock · 11,367 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of this option vested and became exercisable on January 1, 2019, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 45,466 shares and the Reporting Person has exercised his option to purchase 31,258 shares. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 16:04 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionStock Option (Right to Buy) · Derivative | 31,656 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001104659-20-137408 · tm2038926d1_4.xml · derivative · entry 8 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,079 Underlying: Common Stock · 31,656 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of this option vested and became exercisable on March 1, 2018, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 129,212 shares and the Reporting Person has exercised his option to purchase 121,133 shares. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 16:04 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | SaleCommon Stock | 16,478 | $11.76 | $193,781.28 |
DisclosureSEC source: 0001104659-20-137408 · tm2038926d1_4.xml · nonDerivative · entry 6 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,403 F1 · kind: The sales reported on this Form 4 were in connection with the satisfaction of tax obligations and the shares retained upon exercise remain subject to a lockup agreement which expires on March 8, 2021. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 16:04 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionCommon Stock | 29,628 | $0.10 | $2,962.80 |
DisclosureSEC source: 0001104659-20-137408 · tm2038926d1_4.xml · nonDerivative · entry 5 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 16:04 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | SaleCommon Stock | 11,501 | $11.70 | $134,561.70 |
DisclosureSEC source: 0001104659-20-137408 · tm2038926d1_4.xml · nonDerivative · entry 4 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,253 F1 · kind: The sales reported on this Form 4 were in connection with the satisfaction of tax obligations and the shares retained upon exercise remain subject to a lockup agreement which expires on March 8, 2021. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 16:04 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionCommon Stock | 19,360 | $0.10 | $1,936.00 |
DisclosureSEC source: 0001104659-20-137408 · tm2038926d1_4.xml · nonDerivative · entry 3 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 16:04 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionStock Option (Right to Buy) · Derivative | 640 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001104659-20-137408 · tm2038926d1_4.xml · derivative · entry 7 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,735 Underlying: Common Stock · 640 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of this option vested and became exercisable on March 1, 2018, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 129,212 shares and the Reporting Person has exercised his option to purchase 121,133 shares. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 16:04 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | SaleCommon Stock | 380 | $11.70 | $4,446.00 |
DisclosureSEC source: 0001104659-20-137408 · tm2038926d1_4.xml · nonDerivative · entry 2 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,394 F1 · kind: The sales reported on this Form 4 were in connection with the satisfaction of tax obligations and the shares retained upon exercise remain subject to a lockup agreement which expires on March 8, 2021. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 16:04 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionCommon Stock | 640 | $0.10 | $64.00 |
DisclosureSEC source: 0001104659-20-137408 · tm2038926d1_4.xml · nonDerivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 16:01 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | GrantCommon Stock | 2,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-085606 · a4.xml · nonDerivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,134 F1 · shares: The Reporting Person was awarded 2,736 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of HOOKIPA Pharma Inc.'s Common Stock. The restricted stock units vest shall vest in four equal installments on March 20, 2021, May 15, 2021, August 15, 2021 and November 15, 2021. The restricted stock units may be settled only by delivering shares of HOOKIPA Pharma Inc.'s Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| April 20, 2020 Filed Apr 24, 2020 08:55 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | GrantStock Option (Right to Buy) · Derivative | 65,200 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001104659-20-050695 · a4.xml · derivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,200 shares Expires 2030-04-20 F1 · derivative.exercise_date: 25% of this option shall vest on February 15, 2021, with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 16:01 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | SaleCommon Stock | 5,500 | $12.73 | $69,992.45 |
DisclosureSEC source: 0001104659-20-009230 · a4.xml · nonDerivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,398 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.70 to $12.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 08:30 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionStock Option (Right to Buy) · Derivative | 19,891 | $0.10 Strike: $0.10 | $1,989.10 |
DisclosureSEC source: 0001104659-19-075319 · a4.xml · derivative · entry 5 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,575 Underlying: Common Stock · 19,891 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of this option vested and became exercisable on January 1, 2019, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 45,466 shares and the Reporting Person has exercised his option to purchase 19,891 shares. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 08:30 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.10 Strike: $0.10 | $600.00 |
DisclosureSEC source: 0001104659-19-075319 · a4.xml · derivative · entry 4 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,375 Underlying: Common Stock · 6,000 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of this option vested and became exercisable on March 1, 2018, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 129,212 shares and the Reporting Person has exercised his option to purchase 88,837 shares. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 08:30 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | SaleCommon Stock | 10,404 | $9.93 | $103,311.72 |
DisclosureSEC source: 0001104659-19-075319 · a4.xml · nonDerivative · entry 3 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,898 Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 08:30 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionCommon Stock | 19,891 | $0.10 | $1,989.10 |
DisclosureSEC source: 0001104659-19-075319 · a4.xml · nonDerivative · entry 2 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 08:30 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionCommon Stock | 6,000 | $0.10 | $600.00 |
DisclosureSEC source: 0001104659-19-075319 · a4.xml · nonDerivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 16:03 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionStock Option (Right to Buy) · Derivative | 26,312 | $0.10 Strike: $0.10 | $2,631.20 |
DisclosureSEC source: 0001104659-19-074342 · a4.xml · derivative · entry 3 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,375 Underlying: Common Stock · 26,312 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of this option vested and became exercisable on March 1, 2018, with the remainder vesting in 12 equal quarterly installments thereafter. This option was initially for 129,212 shares and the Reporting Person has exercised his option to purchase 82,837 shares. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 16:03 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | SaleCommon Stock | 11,484 | $7.87 | $90,379.08 |
DisclosureSEC source: 0001104659-19-074342 · a4.xml · nonDerivative · entry 2 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,411 Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 16:03 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | Exercise / conversionCommon Stock | 26,312 | $0.10 | $2,631.20 |
DisclosureSEC source: 0001104659-19-074342 · a4.xml · nonDerivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2019 Filed Apr 24, 2019 18:15 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | GrantStock Option (Right to Buy) · Derivative | 52,064 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001104659-19-023470 · a4.xml · derivative · entry 1 Matushansky Igor · CIK 0001768208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,064 Underlying: Common Stock · 52,064 shares Expires 2029-04-17 F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on April 17, 2020, with the remainder vesting in 12 equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.